OPUS GENETICS INC. -
1,1000
25-ноября-24 15:45:01
15 мин. задержка
Акции
+0,0900
+8,91%
Сегодняшний диапазон
1,0200 - 1,1200
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
05 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24 янв 2024 15:10:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII
30 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27 ноя 2023 15:38:14 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Appointment of Joseph Schachle, M.B.A., as Chief Operating Officer
27 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Third Quarter 2023 and Provides Corporate Update
13 ноя 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
02 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 ноя 2023 15:52:46 Источник Nasdaq GlobeNewswire
-
01 ноя 2023 07:05:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at AAO 2023 and Eyecelerator Retina Showcase
26 окт 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Euretina and Retina Society Conferences in October
06 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
27 сен 2023 07:00:12 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Participate in Three Upcoming Investment Bank Conferences
11 сен 2023 08:41:55 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
07 сен 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Abstract on ZETA-1 Study of APX3330 Receives Award at Women in Ophthalmology (WIO) Summer Symposium
28 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for Second Quarter 2023 and Provides Corporate Update
11 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
08 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
26 июл 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 июл 2023 16:19:14 Источник Nasdaq GlobeNewswire